Aurelie Kamoun
Overview
Explore the profile of Aurelie Kamoun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1535
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Linsen S, Kamoun A, Gunda A, Mwenifumbo T, Chavula C, Nchimunya L, et al.
PLOS Digit Health
. 2025 Jan;
4(1):e0000535.
PMID: 39847594
AI based software, including computer aided detection software for chest radiographs (CXR-CAD), was developed during the pandemic to improve COVID-19 case finding and triage. In high burden TB countries, the...
2.
Lopez R, Garcia A, Chura Aruni J, Balboa V, Rodriguez A, Erkosar B, et al.
PLoS Negl Trop Dis
. 2024 Mar;
18(3):e0012016.
PMID: 38437237
Bolivia has the highest incidence of Chagas disease (CD) worldwide. Caused by the parasite Trypanasoma cruzi, CD is generally a chronic condition. Diagnosis is logistically and financially challenging, requiring at...
3.
Saillard C, Dubois R, Tchita O, Loiseau N, Garcia T, Adriansen A, et al.
Nat Commun
. 2023 Nov;
14(1):6695.
PMID: 37932267
Mismatch Repair Deficiency (dMMR)/Microsatellite Instability (MSI) is a key biomarker in colorectal cancer (CRC). Universal screening of CRC patients for MSI status is now recommended, but contributes to increased workload...
4.
Saillard C, Delecourt F, Schmauch B, Moindrot O, Svrcek M, Bardier-Dupas A, et al.
Nat Commun
. 2023 Jun;
14(1):3459.
PMID: 37311751
Two tumor (Classical/Basal) and stroma (Inactive/active) subtypes of Pancreatic adenocarcinoma (PDAC) with prognostic and theragnostic implications have been described. These molecular subtypes were defined by RNAseq, a costly technique sensitive...
5.
Shi M, Fontugne J, Moreno-Vega A, Meng X, Groeneveld C, Dufour F, et al.
Eur Urol
. 2022 Oct;
83(1):70-81.
PMID: 36273937
Background: Bladder cancer (BCa) is more common in men and presents differences in molecular subtypes based on sex. Fibroblast growth factor receptor 3 (FGFR3) mutations are enriched in the luminal...
6.
Lang H, Beraud C, Cabel L, Fontugne J, Lassalle M, Krucker C, et al.
Front Oncol
. 2022 Aug;
12:930731.
PMID: 36033544
Background: Muscle-invasive bladder cancer (MIBC) and upper urinary tract urothelial carcinoma (UTUC) are molecularly heterogeneous. Despite chemotherapies, immunotherapies, or anti-fibroblast growth factor receptor (FGFR) treatments, these tumors are still of...
7.
Schmauch B, Romagnoni A, Pronier E, Saillard C, Maille P, Calderaro J, et al.
Nat Commun
. 2020 Aug;
11(1):3877.
PMID: 32747659
Deep learning methods for digital pathology analysis are an effective way to address multiple clinical questions, from diagnosis to prediction of treatment outcomes. These methods have also been used to...
8.
Kamoun A, De Reynies A, Allory Y, Sjodahl G, Robertson A, Seiler R, et al.
Eur Urol
. 2020 Feb;
77(4):436-438.
PMID: 32037144
No abstract available.
9.
Appay R, Dehais C, Maurage C, Alentorn A, Carpentier C, Colin C, et al.
Neuro Oncol
. 2019 Dec;
21(12):1519-1528.
PMID: 31832685
Background: The 2016 World Health Organization (WHO) classification of central nervous system tumors stratifies isocitrate dehydrogenase (IDH)-mutant gliomas into 2 major groups depending on the presence or absence of 1p/19q...
10.
Kamoun A, De Reynies A, Allory Y, Sjodahl G, Robertson A, Seiler R, et al.
Eur Urol
. 2019 Sep;
77(4):420-433.
PMID: 31563503
Background: Muscle-invasive bladder cancer (MIBC) is a molecularly diverse disease with heterogeneous clinical outcomes. Several molecular classifications have been proposed, but the diversity of their subtype sets impedes their clinical...